- Coordinator
- Exus Software Monoprosopi Etairia Periorismenis Evthinis, Greece
- Runs
- 1 January 2023 to 31 December 2026
- Status
- Running
- EU funding
- €13.0m
- Total cost
- €13.0m
- Partners
- 43 organisations in 16 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101097036
What the project is doing
In the project's own words, from its summary on CORDIS.
With Colorectal Cancer (CRC) being accountable for 12.4% of all deaths due to cancer, and with only 14% of EU citizens participating in screening programmes, there is an urgent need for accurate, non-invasive, cost-effective screening tests based on novel technologies and an increased awareness on the disease and its detection. Furthermore, personalized approaches for screening are needed, to consider genetic and other socioeconomic variables and environmental stressors that lead to different onsets of the disease.
ONCOSCREEN responds to these challenges by developing a risk-based, population-level stratification methodology for CRC, to account for genetic prevalence, socio-economic status, and other factors. It complements this methodology by a) developing a set of novel, practical, and low-cost screening technologies with high sensitivity and specificity, b) leveraging AI to improve existing methodologies for CRC screening, allowing for the early detection of polyps and provision of a personalized risk status stratification, and c) providing a mobile app for self-monitoring and CRC awareness raising.
Furthermore, ONCOSCREEN develops an Intelligent Analytics dashboard for policy makers facilitating effective policy making at regional and national levels. Through a multi-level campaign, the above-mentioned solutions are tested and validated. For the clinical solutions specifically, a clinical validation study has been planned with the participation of 4100 enrolled patients/citizens. To ensure the adoption of the developed solutions by the healthcare systems, their cost-effectiveness and financial viability will be assessed.
The 48-months duration project will be implemented by a multidisciplinary consortium comprising of 38 partners, including technical solutions providers, hospitals, Ministries of Health as policy makers, legal and ethics experts, Insurance companies, involving actively end-users/citizens in all phases of implementation through targeted workshops. This action is part of the Cancer Mission cluster of projects on ‘Prevention, including Screening.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Exus Software Monoprosopi Etairia Periorismenis Evthinis | Athina | Greece | Coordinator |
| Europaische Vereinigung Der Gastrointestinalen Onkologie(european Society of Digestive Oncology - Esdo) | Wien | Austria | Participant |
| Medizinische Universitat Graz | Graz | Austria | Participant |
| Medizinische Universitat Innsbruck | Innsbruck | Austria | Participant |
| Ainigma Technologies | Leuven | Belgium | Participant |
| Innovation Sprint | Bruxelles / Brussel | Belgium | Participant |
| Timelex | Bruxelles / Brussel | Belgium | Participant |
| Vlaamse Instelling Voor Technologisch Onderzoek N.v. | Mol | Belgium | Participant |
| Rosenbaum Consulting | Sofia | Bulgaria | Participant |
| Catalink Limited | Nicosia | Cyprus | Participant |
| Scientific Academy for Service Technology eV | Potsdam | Germany | Participant |
| Universitaet Zu Luebeck | Lubeck | Germany | Third party |
| Universitaetsmedizin Der Johannes Gutenberg-Universitaet Mainz | Mainz | Germany | Participant |
| Universitatsklinikum Schleswig-Holstein | Lübeck | Germany | Participant |
| Elliniki Etaireia Ogkologias Peptikou | Chaidari Athina | Greece | Participant |
| Erevnitiko Panepistimiako Institouto Systimaton Epikoinonion Kai Ypologiston | Athina | Greece | Participant |
| Ethniko Kentro Erevnas Kai Technologikis Anaptyxis | Thermi Thessaloniki | Greece | Participant |
| Geniko Nosokomeio Elena Venizelou -Alexandra | Athina | Greece | Participant |
| Ypourgeio Ygeias | Athina | Greece | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Universidad De La Rioja | Logrono | Spain | Participant |
| Association Gercor | Paris | France | Participant |
| Firalis | Huningue | France | Participant |
| Gie Axa | Paris | France | Participant |
| Universite Marie Et Louis Pasteur | Besancon | France | Participant |
| Carr Communications Limited | Dublin | Ireland | Participant |
| Konnekt Able Technologies Limited | Dundalk Co Louth | Ireland | Participant |
| Technion - Israel Institute of Technology | Haifa | Israel | Participant |
| Ey Advisory SpA | Milano | Italy | Participant |
| Lietuvos Respublikos Sveikatos Apsaugos Ministerija | Vilnius | Lithuania | Participant |
| Lietuvos Sveikatos Mokslu Universitetas | Kaunas | Lithuania | Participant |
| Pagalbos Onkologiniams Ligoniams Asociacija | Kaunas | Lithuania | Participant |
| Louwen Rogier | Oosterhout | Netherlands | Participant |
| Tilburg University- Universiteit Van Tilburg | Tilburg | Netherlands | Participant |
| Voogd Sanne | Roosendaal | Netherlands | Participant |
| Europacolon Portugal- Associacao De Luta Contra O Cancro Do Intestino | Porto | Portugal | Participant |
| Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe | Porto | Portugal | Participant |
| Universidade Do Minho | Braga | Portugal | Participant |
| Beia Consult International SRL | Bucuresti | Romania | Participant |
| Delta Health Care S.R.L | Bucharest - District 1 | Romania | Participant |
| Fundatia Youth Cancer Europe | Cluj Napoca | Romania | Participant |
| Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti | Bucharest | Romania | Participant |
| Fakultna Nemocnica S Poliklinikou F.d. Roosevelta Banska Bystrica | Banska Bystrica | Slovakia | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI